Facilitating the research of numerous nationally and internationally recognized scientists, in over sixty labs across British Columbia, to improve cancer care.

BC Cancer Research strives to improve the lives of patients through the integration of basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the development of innovative new technology, programs, and interventions. Organized through departments and programs with various themes, BC Cancer supports groundbreaking cancer research and personalized care approaches through world-class facilities and platforms including genomics, bioinformatics, imaging, drug development and tissue banking.

Our Research

The success of BC Cancer is driven by the people and their passion to reduce the impact of cancer on people and society. Our 2022 Research Report showcases how BC Cancer continues to be internationally recognized for our excellence in cancer research and its integrated model of cancer planning and care. 

Read the 2022 BC Cancer Research Report. 

News & Events

New study explores patient preferences to improve data sharing for precision oncology across Canada

In a new study, a team led by Dr. Dean Regier, Senior Scientist in Cancer Control at BC Cancer and co-chair of the MOHCCN Health Technology Assessment Working Group, conducted focus groups with individuals with lived and living experience with cancer to understand their values, expectations, and concerns for enhanced data sharing.

Join BC Cancer’s third Planetary Health Nursing Internship Program cohort

​​​In our current climate crisis, we understand that the health of our planet impacts human health. The health care industry is a major contributor to greenhouse gases, which have health implications for our patients at BC Cancer, and the population at large. At BC Cancer, we recognize it's our responsibility to evaluate our own contributions to this crisis, and act on innovative and sustainable solutions to tackle this problem.

Save the date! Inaugural GSC Collaborator Forum October 22

Save the date – on October 22nd the GSC will be hosting our first-ever collaborator forum! Please join us for this one-day conference, hear exciting talks from genomics researchers, and engage with the local scientific community and our technology sponsors: Illumina, Oxford Nanopore and PacBio. Registration opening early September!

Save the date! Inaugural GSC Collaborator Forum October 22

Save the date – on October 22nd the GSC will be hosting our first-ever collaborator forum! Please join us for this one-day conference, hear exciting talks from genomics researchers, and engage with the local scientific community and our technology sponsors: Illumina, Oxford Nanopore and PacBio. Registration opening early September!

Congratulations to Tabea Stephan (Hoodless Lab) on receiving a Stem Cell Network 2019 Till & McCulloch Meetings travel award.

Tabea has been awarded this competitive Stem Cell Network travel award to attend the 2019 Till & McCulloch Meetings (TMM2019) and present her work on deciphering epigenetic dynamics during in vitro hepatocyte differentiation. TMM2019 will be held in Montréal, Québec, November 4-6, 2019.
 

Research Recovery Resources

BC Cancer Research is taking a gradual and careful approach to re-opening research activities to protect our staff, patients and communities.

Access our COVID-19 recovery resources.

Our Strategic Plan

Our Strategic Plan outlines our direction to strengthen our research capabilities and collaboration with departments and partners to improve our ability to generate knowledge, enhance the impact of our research, and support innovation in clinical care.  

Read the BC Cancer Research Strategic Plan.

Facilitating research excellence through management of day-to-day operations.

Office of Research Administration

Conducting research to improve the prevention, detection and treatment of cancer.

Cancer Control Research

Developing and deploying genomics technologies and services in support of cancer and life sciences research.

Genome Sciences Centre

Making novel discoveries in the biology underlying normal development and cancer progression.

Terry Fox Laboratory

Characterising the molecular changes that underpin the progression and pathogenesis of cancer.

Molecular Oncology

Researching the optical, radiobiological and genetic properties of cancer.

Integrative Oncology

Improving patient outcomes by gaining a deeper understanding of lymphoma biology and progression, for use in clinical applications.

Lymphoid Cancer Research

Defining better intervention strategies for individuals diagnosed with aggressive cancers.

Experimental Therapeutics

Clinical Research

Harnessing the immune system to detect and treat cancer.

Deeley Research Centre

The Nursing and Allied Health Research and Knowledge Translation department promotes innovation and excellence in interprofessional research and knowledge mobilization to drive evidence-informed improvements in care, better patient outcomes and increased system performance.

Nursing and Allied Health Research and Knowledge Translation

Publications

Back to top